The present study was a secondary analysis of the INTRECIS study (12), which was the largest-sample cohort that included multiple doses of intravenous r-tPA for Chinese AIS, however, several limitations still remained in the current analysis. This evidence concerns the gene PLAT and androgen insensitivity syndrome.